Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripSun, 12 Jul 2026 21:44:53 +0000en1hourly1 https://insights.citeline.com/scrip/business/deals/gileads-biggest-buys-balance-drug-candidate-needs-with-platform-desires-J7Y2EEELAFC7BF7LE435NXAR3U/<![CDATA[Gilead’s Biggest Buys Balance Drug Candidate Needs With Platform Desires]]>premium

      
]]> https://feeds.feedblitz.com/~/960036575/0/scrip~Gilead%e2%80%99s-Biggest-Buys-Balance-Drug-Candidate-Needs-With-Platform-Desires/https://insights.citeline.com/scrip/business/deals/gileads-biggest-buys-balance-drug-candidate-needs-with-platform-desires-J7Y2EEELAFC7BF7LE435NXAR3U/
      
]]> Fri, 10 Jul 2026 21:05:26 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/roche-pulls-plug-on-two-antisense-oligonucleotide-programs-in-huntingtons-7E3EVZYK3NAF3J5OJXSNPSVNV4/<![CDATA[Roche Pulls Plug On Two Antisense Oligonucleotide Programs In Huntington’s]]>premium

      
]]> https://feeds.feedblitz.com/~/960036578/0/scrip~Roche-Pulls-Plug-On-Two-Antisense-Oligonucleotide-Programs-In-Huntington%e2%80%99s/https://insights.citeline.com/scrip/r-and-d/clinical-trials/roche-pulls-plug-on-two-antisense-oligonucleotide-programs-in-huntingtons-7E3EVZYK3NAF3J5OJXSNPSVNV4/
      
]]> Fri, 10 Jul 2026 21:02:53 +0000 https://insights.citeline.com/scrip/business/financing/bayer-break-up-rumors-revived-after-3bn-apollo-pact-35NR6MJMHJAFLGFCPOBJNZVMIM/<![CDATA[Bayer Break-Up Rumors Revived After €3bn Apollo Pact]]>premium

      
]]> https://feeds.feedblitz.com/~/960004757/0/scrip~Bayer-BreakUp-Rumors-Revived-After-%e2%82%acbn-Apollo-Pact/https://insights.citeline.com/scrip/business/financing/bayer-break-up-rumors-revived-after-3bn-apollo-pact-35NR6MJMHJAFLGFCPOBJNZVMIM/
      
]]> Fri, 10 Jul 2026 13:21:32 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/leo-reports-phase-ii-pediatric-data-as-tralokinumab-advances-through-phase-iii-KQMFNS6Z45DVPB6KNN3MGRAFBE/<![CDATA[LEO Reports Phase II Pediatric Data As Tralokinumab Advances Through Phase III]]>premium

      
]]> https://feeds.feedblitz.com/~/960013526/0/scrip~LEO-Reports-Phase-II-Pediatric-Data-As-Tralokinumab-Advances-Through-Phase-III/https://insights.citeline.com/scrip/r-and-d/clinical-trials/leo-reports-phase-ii-pediatric-data-as-tralokinumab-advances-through-phase-iii-KQMFNS6Z45DVPB6KNN3MGRAFBE/
      
]]> Fri, 10 Jul 2026 14:55:21 +0000 https://insights.citeline.com/scrip/business/earnings/pharma-at-the-midyear-taking-stock-of-financial-forecasts-T2ZPE5JF3BAA7NV6U24S5K6JMM/<![CDATA[Pharma At The Midyear: Taking Stock Of Financial Forecasts ]]>premium

      
]]> https://feeds.feedblitz.com/~/960034874/0/scrip~Pharma-At-The-Midyear-Taking-Stock-Of-Financial-Forecasts/https://insights.citeline.com/scrip/business/earnings/pharma-at-the-midyear-taking-stock-of-financial-forecasts-T2ZPE5JF3BAA7NV6U24S5K6JMM/
      
]]> Fri, 10 Jul 2026 20:32:26 +0000 https://insights.citeline.com/scrip/r-and-d/global-phase-iii-trial-for-serum-institutevisterras-dengue-candidate-sharing-voyxact-platform-BOYZPV4A3FAZZJE7U6RMJBEKSU/<![CDATA[Global Phase III Trial For Serum Institute/Visterra’s Dengue Candidate Sharing Voyxact Platform ]]>premium

      
]]> https://feeds.feedblitz.com/~/959988689/0/scrip~Global-Phase-III-Trial-For-Serum-InstituteVisterra%e2%80%99s-Dengue-Candidate-Sharing-Voyxact-Platform/https://insights.citeline.com/scrip/r-and-d/global-phase-iii-trial-for-serum-institutevisterras-dengue-candidate-sharing-voyxact-platform-BOYZPV4A3FAZZJE7U6RMJBEKSU/
      
]]> Fri, 10 Jul 2026 09:18:42 +0000 https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-eight-ceos-and-three-cfos-among-this-weeks-changes-6CBPDIU25BFC5BT5FVYLMMQITA/<![CDATA[Executives On The Move: Eight CEOs And Three CFOs Among This Week’s Changes]]>premium

      
]]> https://feeds.feedblitz.com/~/959999810/0/scrip~Executives-On-The-Move-Eight-CEOs-And-Three-CFOs-Among-This-Week%e2%80%99s-Changes/https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-eight-ceos-and-three-cfos-among-this-weeks-changes-6CBPDIU25BFC5BT5FVYLMMQITA/
      
]]> Fri, 10 Jul 2026 11:48:03 +0000